Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Work In Process (2016 - 2025)

Historic Work In Process for InspireMD (NSPR) over the last 15 years, with Q3 2025 value amounting to $733000.0.

  • InspireMD's Work In Process rose 3159.78% to $733000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $733000.0, marking a year-over-year increase of 3159.78%. This contributed to the annual value of $638000.0 for FY2024, which is 1352.31% up from last year.
  • According to the latest figures from Q3 2025, InspireMD's Work In Process is $733000.0, which was up 3159.78% from $865000.0 recorded in Q2 2025.
  • InspireMD's 5-year Work In Process high stood at $865000.0 for Q2 2025, and its period low was $223000.0 during Q1 2021.
  • Over the past 5 years, InspireMD's median Work In Process value was $525000.0 (recorded in 2023), while the average stood at $535555.6.
  • As far as peak fluctuations go, InspireMD's Work In Process crashed by 2064.06% in 2021, and later soared by 12287.0% in 2022.
  • InspireMD's Work In Process (Quarter) stood at $436000.0 in 2021, then increased by 16.97% to $510000.0 in 2022, then rose by 10.2% to $562000.0 in 2023, then increased by 13.52% to $638000.0 in 2024, then increased by 14.89% to $733000.0 in 2025.
  • Its Work In Process was $733000.0 in Q3 2025, compared to $865000.0 in Q2 2025 and $823000.0 in Q1 2025.